Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article (101)

Advertisement

Research Article Free access | 10.1172/JCI114768

Thyroid-stimulating antibody activity between different immunoglobulin G subclasses.

A P Weetman, M E Yateman, P A Ealey, C M Black, C B Reimer, R C Williams Jr, B Shine, and N J Marshall

Department of Medicine, University of Cambridge Clinical School, Addenbrooke's Hospital, United Kingdom.

Find articles by Weetman, A. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Cambridge Clinical School, Addenbrooke's Hospital, United Kingdom.

Find articles by Yateman, M. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Cambridge Clinical School, Addenbrooke's Hospital, United Kingdom.

Find articles by Ealey, P. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Cambridge Clinical School, Addenbrooke's Hospital, United Kingdom.

Find articles by Black, C. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Cambridge Clinical School, Addenbrooke's Hospital, United Kingdom.

Find articles by Reimer, C. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Cambridge Clinical School, Addenbrooke's Hospital, United Kingdom.

Find articles by Williams, R. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Cambridge Clinical School, Addenbrooke's Hospital, United Kingdom.

Find articles by Shine, B. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Cambridge Clinical School, Addenbrooke's Hospital, United Kingdom.

Find articles by Marshall, N. in: JCI | PubMed | Google Scholar

Published September 1, 1990 - More info

Published in Volume 86, Issue 3 on September 1, 1990
J Clin Invest. 1990;86(3):723–727. https://doi.org/10.1172/JCI114768.
© 1990 The American Society for Clinical Investigation
Published September 1, 1990 - Version history
View PDF
Abstract

To investigate the distribution of thyroid-stimulating antibody (TSAb) activity between IgG subclasses, sera from 11 patients with Graves disease (including the National Institute of Biological Standards and Control (NIBSC) Research Standard, long acting thyroid stimulator-B) were fractionated by chromatography on affinity columns of monoclonal IgG subclass antibodies or protein A to deplete all but a single subclass. The resulting fractions were 98% or more pure for a single subclass. In all 11 patients, TSAb activity appeared to be confined to the IgG1 fraction as determined by cAMP production on addition of the fractions to the FRTL-5 rat thyroid cell line. In all of eight specimens from seven patients so tested, the whole serum activity was recovered in the IgG1 fraction, after adjusting for the recovery of the isotype from the column. TSAb activity in one serum comprised both lambda and kappa light chains but was IgG1 restricted. This IgG subclass restriction was not found when the same fractions were tested for thyroglobulin, microsomal/thyroid peroxidase, or tetanus toxoid antibody activity. Together with previous results showing marked restriction of both light chain usage and isoelectric point of TSAb, these results support the idea that Graves' disease may be the result of an oligo- or possibly monoclonal response at the B cell level.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 723
page 723
icon of scanned page 724
page 724
icon of scanned page 725
page 725
icon of scanned page 726
page 726
icon of scanned page 727
page 727
Version history
  • Version 1 (September 1, 1990): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article (101)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts